CVE:CZO Ceapro (CZO) Stock Price, News & Analysis C$0.22 -0.03 (-11.76%) As of 05/31/2024 Add Compare Share Share Stock Analysis Stock Analysis About Ceapro Stock (CVE:CZO) Get Ceapro alerts:Sign Up Key Stats Today's RangeC$0.23▼C$0.2450-Day RangeC$0.23▼C$0.2352-Week RangeC$0.15▼C$0.54Volume5,850 shsAverage Volume50,562 shsMarket CapitalizationC$688.88 thousandP/E RatioN/ADividend Yield1.80%Price TargetN/AConsensus RatingN/A Company Overview Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. Read More Receive CZO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ceapro and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CZO Stock News HeadlinesUniversal Music Restructuring Continues, East Coast Labels Unite via Republic Corps DivisionMarch 12, 2024 | nz.finance.yahoo.comA Complete Breakdown of Kate Middleton's Photoshop ControversyMarch 12, 2024 | nz.finance.yahoo.comWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.August 26 at 1:00 AM | Awesomely (Ad)Canadian Investment Regulatory Organization Trade Resumption - CZODecember 14, 2023 | finance.yahoo.comAeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical CompanyDecember 14, 2023 | finance.yahoo.comCeapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational HighlightsNovember 29, 2023 | finance.yahoo.comPSA: Charlotte Tilbury's Mystery Box is back, and there's a huge surprise in storeNovember 27, 2023 | nz.finance.yahoo.comCeapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based DiseasesNovember 27, 2023 | finance.yahoo.comSee More Headlines CZO Stock Analysis - Frequently Asked Questions How have CZO shares performed this year? Ceapro's stock was trading at C$0.23 at the start of the year. Since then, CZO shares have increased by 0.0% and is now trading at C$0.23. How do I buy shares of Ceapro? Shares of CZO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Ceapro own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ceapro investors own include Franco-Nevada (FNV), Facedrive (FDVRF), FLYHT Aerospace Solutions (FLY), Ackroo (AKR), Badger Daylighting (BAD), BeWhere (BEW) and BlueRush (BTV). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolCVE:CZO CIKN/A Webwww.ceapro.com Phone+1-780-4214555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.08) Trailing P/E RatioN/A Forward P/E Ratio5.63 P/E GrowthN/ANet Income-C$243.04 thousand Net Margins-48.89% Pretax MarginN/A Return on Equity-15.66% Return on Assets-11.30% Debt Debt-to-Equity Ratio8.07 Current Ratio8.54 Quick Ratio18.88 Sales & Book Value Annual SalesC$348.52 thousand Price / Sales1.98 Cash FlowC$0.06 per share Price / Cash Flow3.94 Book ValueC$0.36 per share Price / Book0.63Miscellaneous Outstanding Shares3,061,689Free FloatN/AMarket CapC$688.88 thousand OptionableNot Optionable Beta1.38 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (CVE:CZO) was last updated on 8/26/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredChina is not hedging. It's escaping.China's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low...Behind the Markets | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredNear retirement? Buy this stockOn August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ceapro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ceapro With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
